Clinical Trials Browser

Phase 2 × Neoplasms, Plasma Cell × dexamethasone acetate × Clear all

NCT03641456 2023-06-18

VRD as Induction Followed by VR Maintenance in Patients With Newly Diagnosed High Risk Multiple Myeloma

Phase 2 Unknown

Neoplasms, Plasma Cell

NCT00635154 2018-06-07

Anakinra With or Without Dexamethasone in Treating Patients With Smoldering or Indolent Multiple Myeloma

Phase 2 Completed

55 enrolled 14 charts

Multiple Myeloma, Neoplasms, Plasma Cell